NASDAQ : NCEL
NewcelX Ltd. — Financial statements
Healthcare · Biotechnology · Switzerland
Last price 2.55 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 14.73M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 2.33M | 1.35M | 805.00K | 1.41M | 1.97M | 2.31M |
| Research & Development | 1.72M | 1.13M | 992.00K | 1.61M | 4.29M | 5.50M |
| Other Operating Expenses | -13.00K | 88.00K | 269.00K | |||
| Operating Expenses | 4.03M | 2.56M | 2.07M | 3.02M | 6.26M | 7.81M |
| Operating Income | -4.03M | -2.56M | -2.07M | -3.02M | -6.26M | -7.81M |
| Interest Expense | -6.01M | -5.04M | -239.00K | -78.21K | -148.54K | |
| Interest & Investment Income | 4.26M | 369.00K | 6.00K | 36.00K | ||
| Currency Exchange Gain (Loss) | 7.39K | -2.25K | ||||
| Other Non Operating Income (Expenses) | -179.00K | -99.00K | -93.00K | -114.00K | -178.03K | -627.27K |
| EBT Excluding Unusual Items | 55.00K | -8.30M | -7.20M | -3.33M | -6.51M | -8.59M |
| Pretax Income | 55.00K | -8.30M | -7.20M | -3.33M | -6.51M | -8.59M |
| Income Tax Expense | -47.49K | -142.43K | ||||
| Net Income | 55.00K | -8.30M | -7.20M | -3.33M | -6.46M | -8.45M |
| Net Income to Common | -2.67M | -8.30M | -7.20M | -3.33M | -6.46M | -8.45M |
| Shares Outstanding (Basic) | 5.24M | 3.84M | 2.96M | 2.96M | 3.49M | 2.40M |
| Shares Outstanding (Diluted) | 5.24M | 3.84M | 2.96M | 2.96M | 3.49M | 2.40M |
| EPS (Basic) | -0.51 | -2.16 | -2.43 | -1.13 | -1.85 | -3.53 |
| EPS (Diluted) | -0.51 | -2.16 | -2.43 | -1.13 | -1.85 | -3.53 |
| Free Cash Flow | -5.04M | -2.77M | -1.07M | -3.45M | -5.87M | -7.10M |
| Free Cash Flow Per Share | -0.96 | -0.72 | -0.36 | -1.17 | -1.68 | -2.96 |
| EBITDA | -3.98M | -2.51M | -1.65M | -2.40M | -5.71M | -7.22M |
| D&A For EBITDA | 52.00K | 55.00K | 413.00K | 620.00K | 551.72K | 593.51K |
| EBIT | -4.03M | -2.56M | -2.07M | -3.02M | -6.26M | -7.81M |
| Advertising Expenses | 85.03K | 144.68K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 710.00K | 2.20M | 650.00K | 1.15M | 1.82M | 7.49M |
| Cash & Short-Term Investments | 710.00K | 2.20M | 650.00K | 1.15M | 1.82M | 7.49M |
| Other Receivables | 50.00K | 229.00K | 69.00K | 439.01K | 221.82K | 127.00K |
| Receivables | 50.00K | 229.00K | 69.00K | 439.01K | 221.82K | 127.00K |
| Prepaid Expenses | 235.00K | 293.00K | 61.00K | 14.99K | 69.68K | 92.27K |
| Other Current Assets | 459.00K | 459.00K | ||||
| Total Current Assets | 1.45M | 3.18M | 780.00K | 1.61M | 2.11M | 7.71M |
| Property, Plant & Equipment | 78.00K | 95.00K | 123.00K | 543.69K | 1.28M | 903.45K |
| Goodwill | 1.73M | 1.73M | ||||
| Other Intangible Assets | 6.44M | 6.44M | ||||
| Other Long-Term Assets | 171.60K | 162.96K | 179.08K | |||
| Total Assets | 9.70M | 11.45M | 903.00K | 2.32M | 3.55M | 8.79M |
| Accounts Payable | 961.00K | 1.03M | 206.00K | 133.84K | 649.26K | 562.97K |
| Accrued Expenses | 632.00K | 1.13M | 525.00K | 629.50K | 762.45K | 1.11M |
| Short-Term Debt | 392.00K | 355.00K | 7.73M | 1.39M | 1.19M | 1.36M |
| Current Portion of Leases | 363.76K | 398.71K | 432.43K | |||
| Current Unearned Revenue | 442.00K | 127.64K | ||||
| Other Current Liabilities | 1.01M | |||||
| Total Current Liabilities | 3.66M | 4.20M | 8.90M | 3.53M | 3.00M | 3.59M |
| Long-Term Leases | 443.93K | 122.50K | ||||
| Pension & Post-Retirement Benefits | 5.28K | 19.34K | 128.93K | |||
| Total Liabilities | 3.66M | 4.20M | 8.90M | 3.53M | 3.46M | 3.85M |
| Common Stock | 328.00K | 291.00K | 184.00K | 1.16M | 1.04M | 1.08M |
| Additional Paid-In Capital | 98.02M | 93.69M | 69.50M | 60.77M | 58.26M | 63.93M |
| Retained Earnings | -90.48M | -84.89M | -76.59M | -68.77M | -67.00M | -68.55M |
| Comprehensive Income & Other | -1.83M | -1.84M | -1.09M | 5.62M | 7.80M | 8.48M |
| Total Common Equity | 6.04M | 7.25M | -8.00M | -1.21M | 92.71K | 4.95M |
| Shareholders' Equity | 6.04M | 7.25M | -8.00M | -1.21M | 92.71K | 4.95M |
| Total Liabilities & Equity | 9.70M | 11.45M | 903.00K | 2.32M | 3.55M | 8.79M |
| Total Debt | 392.00K | 355.00K | 7.73M | 1.76M | 2.03M | 1.91M |
| Net Cash (Debt) | 318.00K | 1.85M | -7.08M | -602.28K | -210.16K | 5.58M |
| Net Cash Per Share | 0.06 | 0.48 | -2.39 | -0.20 | -0.06 | 2.33 |
| Filing Date Shares Outstanding | 5.38M | 5.35M | 4.19M | 4.19M | 4.19M | 3.37M |
| Total Common Shares Outstanding | 5.38M | 4.80M | 4.19M | 4.19M | 3.64M | 3.37M |
| Working Capital | -2.21M | -1.01M | -8.12M | -1.92M | -886.44K | 4.11M |
| Book Value Per Share | 1.12 | 1.51 | -1.91 | -0.29 | 0.03 | 1.47 |
| Tangible Book Value | -2.13M | -922.00K | -8.00M | -1.21M | 92.71K | 4.95M |
| Tangible Book Value Per Share | -0.40 | -0.19 | -1.91 | -0.29 | 0.03 | 1.47 |
| Machinery | 1.23M | 1.05M | 1.35M | 2.16M | 2.25M | |
| Leasehold Improvements | 152.00K | 134.00K | 133.56K | 138.21K | 147.90K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 55.00K | -8.30M | -7.20M | -3.33M | -6.46M | -8.45M |
| Depreciation & Amortization | 52.00K | 55.00K | 413.00K | 620.00K | 551.72K | 593.51K |
| Loss (Gain) From Sale of Assets | -34.00K | -50.16K | ||||
| Stock-Based Compensation | 582.00K | 765.00K | 208.00K | 149.00K | 230.93K | 105.14K |
| Other Operating Activities | -4.04M | 5.78M | 4.77M | -81.00K | 273.01K | 646.24K |
| Change in Accounts Receivable | -97.55K | 217.34K | ||||
| Change in Accounts Payable | -1.65M | -869.00K | 415.00K | -601.00K | 144.47K | -206.73K |
| Change in Unearned Revenue | -112.90K | 127.64K | ||||
| Change in Other Net Operating Assets | -33.00K | -201.00K | 321.00K | -165.00K | -215.57K | 87.45K |
| Operating Cash Flow | -5.04M | -2.77M | -1.07M | -3.44M | -5.69M | -6.93M |
| Capital Expenditures | -8.00K | -8.00K | -6.00K | -6.00K | -182.01K | -172.33K |
| Sale of Property, Plant & Equipment | 109.00K | 50.16K | ||||
| Cash Acquisitions | 1.71M | 1.71M | ||||
| Other Investing Activities | -4.55K | |||||
| Investing Cash Flow | 1.70M | 1.70M | -6.00K | 103.00K | -186.56K | -122.17K |
| Short-Term Debt Issued | 290.00K | 450.00K | 1.24M | 482.27K | ||
| Total Debt Issued | 12.00K | 290.00K | 450.00K | 1.24M | 482.27K | |
| Short-Term Debt Repaid | -1.13M | |||||
| Long-Term Debt Repaid | -497.97K | -445.62K | ||||
| Lease Payments | -497.97K | -445.62K | ||||
| Total Debt Repaid | -497.97K | -1.57M | ||||
| Net Debt Issued (Repaid) | 12.00K | 290.00K | 450.00K | 1.24M | -497.97K | -1.09M |
| Issuance of Common Stock | 3.71M | 2.34M | 1.61M | 1.56M | 13.88M | |
| Financing Cash Flow | 3.72M | 2.63M | 450.00K | 2.85M | 1.06M | 12.79M |
| Foreign Exchange Rate Adjustments | 30.00K | -12.00K | -44.00K | -166.00K | 7.68K | -2.25K |
| Net Cash Flow | 411.00K | 1.55M | -666.00K | -658.00K | -4.81M | 5.74M |
| Free Cash Flow | -5.04M | -2.77M | -1.07M | -3.45M | -5.87M | -7.10M |
| Free Cash Flow Per Share | -0.96 | -0.72 | -0.36 | -1.17 | -1.68 | -2.96 |
| Levered Free Cash Flow | -12.32M | -2.73M | -4.10M | -1.05M | -3.64M | -4.26M |
| Unlevered Free Cash Flow | -12.32M | 1.03M | -951.66K | -896.74K | -3.59M | -4.17M |
| Free Cash Flow After Leases | -5.04M | -2.77M | -1.07M | -3.45M | -6.37M | -7.55M |
| Cash Interest Paid | 20.00K | 20.00K | 133.00K | 90.00K | 65.41K | 148.86K |
| Cash Income Tax Paid | 2.00K | 1.00K | ||||
| Change in Working Capital | -1.68M | -1.07M | 736.00K | -766.00K | -281.55K | 225.70K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 14.73M | 8.66M | ||||
| Enterprise Value | 14.41M | 10.91M | ||||
| Last Close Price | 2.55 | 1.90 | ||||
| PB Ratio | 2.27 | 1.20 | ||||
| Debt / Equity Ratio | 0.07 | 0.05 | -0.97 | -1.45 | 21.87 | 0.39 |
| Net Debt / Equity Ratio | -0.05 | -0.26 | -0.89 | -0.50 | 2.27 | -1.13 |
| Net Debt / EBITDA Ratio | 0.08 | 0.74 | -4.28 | -0.25 | -0.04 | 0.77 |
| Net Debt / FCF Ratio | 0.06 | 0.67 | -6.60 | -0.17 | -0.04 | 0.79 |
| Quick Ratio | 0.21 | 0.58 | 0.08 | 0.45 | 0.68 | 2.12 |
| Current Ratio | 0.40 | 0.76 | 0.09 | 0.46 | 0.70 | 2.15 |
| Return on Equity (ROE) | -289.25% | -717.90% | ||||
| Return on Assets (ROA) | -49.59% | -25.94% | -80.05% | -65.08% | -69.07% | -79.65% |
| Return on Capital Employed (ROCE) | -66.70% | -35.30% | 25.80% | 250.10% | -1,125.80% | -150.30% |
| Earnings Yield | -19.97% | -95.83% | ||||
| FCF Yield | -34.25% | -32.03% | ||||
| Buyback Yield / Dilution | -117.41% | -29.89% | -0.14% | 15.26% | -45.50% | -62.50% |